Iloprost Drugs Market Revenue 2024 to 2034
Iloprost Drugs Market Revenue 2024 to 2034
The Iloprost Drugs Market is projected to expand from USD 7.31 Bn in 2024 to USD 19.21 Bn by 2034, at a CAGR of 10.1%. Growth is fueled by rising cases of pulmonary arterial hypertension (PAH), increasing adoption of prostacyclin analogs, and advancements in inhalation and infusion drug delivery systems.
Report ID: 10363
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 7.31 Bn
Forecast Year,
USD 19.21 Bn
CAGR, 2025 -
10.15%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Iloprost Drugs Market Size Analysis
Iloprost Drugs Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 2.34 | 2.58 | 2.85 | 3.12 | 3.43 | 3.77 | 4.13 | 4.55 | 4.99 | 5.49 | 6.11 |
| Biologics | 2.48 | 2.74 | 3.00 | 3.33 | 3.67 | 4.05 | 4.47 | 4.93 | 5.44 | 6.00 | 6.59 |
| Advanced Therapies | 1.32 | 1.44 | 1.59 | 1.75 | 1.93 | 2.13 | 2.35 | 2.59 | 2.86 | 3.15 | 3.45 |
| Others | 1.17 | 1.29 | 1.42 | 1.57 | 1.73 | 1.90 | 2.10 | 2.31 | 2.54 | 2.80 | 3.06 |
Iloprost Drugs Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 2.63 | 2.90 | 3.19 | 3.50 | 3.88 | 4.30 | 4.76 | 5.23 | 5.76 | 6.34 | 7.03 |
| Cardio-Metabolic | 1.32 | 1.44 | 1.59 | 1.76 | 1.94 | 2.12 | 2.34 | 2.59 | 2.85 | 3.13 | 3.45 |
| Infectious | 1.17 | 1.28 | 1.42 | 1.57 | 1.71 | 1.89 | 2.07 | 2.29 | 2.54 | 2.80 | 3.07 |
| CNS | 1.02 | 1.13 | 1.25 | 1.38 | 1.51 | 1.65 | 1.80 | 1.99 | 2.18 | 2.41 | 2.65 |
| Others | 1.17 | 1.29 | 1.41 | 1.56 | 1.72 | 1.89 | 2.08 | 2.28 | 2.50 | 2.77 | 3.01 |
Iloprost Drugs Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 3.21 | 3.55 | 3.90 | 4.31 | 4.75 | 5.25 | 5.78 | 6.37 | 7.00 | 7.70 | 8.47 |
| Retail Pharmacy | 2.63 | 2.89 | 3.18 | 3.49 | 3.84 | 4.22 | 4.66 | 5.11 | 5.61 | 6.20 | 6.84 |
| Online/Other | 1.46 | 1.62 | 1.78 | 1.96 | 2.17 | 2.38 | 2.62 | 2.90 | 3.23 | 3.55 | 3.90 |
Iloprost Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.92 | 3.21 | 3.52 | 3.90 | 4.30 | 4.71 | 5.18 | 5.68 | 6.24 | 6.86 | 7.57 |
| Europe | 2.05 | 2.27 | 2.51 | 2.78 | 3.05 | 3.36 | 3.68 | 4.10 | 4.54 | 5.03 | 5.55 |
| Asia Pacific | 1.75 | 1.93 | 2.13 | 2.31 | 2.55 | 2.83 | 3.14 | 3.44 | 3.79 | 4.15 | 4.55 |
| Latin America | 0.29 | 0.32 | 0.35 | 0.38 | 0.42 | 0.47 | 0.52 | 0.56 | 0.62 | 0.68 | 0.76 |
| Middle East & Africa | 0.29 | 0.32 | 0.35 | 0.39 | 0.43 | 0.48 | 0.53 | 0.59 | 0.65 | 0.72 | 0.79 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
